NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is 67076P102. A total of 32 filers reported holding NYMOX PHARMACEUTICAL CORP in Q1 2014. The put-call ratio across all filers is 1.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $96,000 | +159.5% | 28,000 | 0.0% | 0.04% | +191.7% |
| Q2 2015 | $37,000 | +54.2% | 28,000 | 0.0% | 0.01% | +50.0% |
| Q1 2015 | $24,000 | +118.2% | 28,000 | 0.0% | 0.01% | +100.0% |
| Q4 2014 | $11,000 | -84.3% | 28,000 | +75.0% | 0.00% | -84.6% |
| Q3 2014 | $70,000 | +27.3% | 16,000 | +45.5% | 0.03% | +30.0% |
| Q2 2014 | $55,000 | -8.3% | 11,000 | 0.0% | 0.02% | -16.7% |
| Q1 2014 | $60,000 | -1.6% | 11,000 | +10.0% | 0.02% | -4.0% |
| Q4 2013 | $61,000 | – | 10,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MARATHON CAPITAL MANAGEMENT | 92,700 | $614,000 | 0.53% |
| WMS Partners, LLC | 59,350 | $392,000 | 0.08% |
| Eidelman Virant Capital | 18,944 | $125,000 | 0.06% |
| GOFEN & GLOSSBERG LLC /IL/ | 25,000 | $166,000 | 0.01% |
| MACROVIEW INVESTMENT MANAGEMENT LLC | 550 | $4,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 12,300 | $81,000 | 0.01% |
| Virtu KCG Holdings LLC | 57,663 | $379,000 | 0.01% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 12,400 | $82,000 | 0.00% |
| DF DENT & CO INC | 15,000 | $99,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 12,095 | $80,000 | 0.00% |